SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-054858
Filing Date
2006-03-15
Accepted
2006-03-15 14:42:01
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR THE PERIOD ENDED DECEMBER 31, 2005 d10k.htm 10-K 1688785
2 CODE OF ETHICS dex14.htm EX-14 78335
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 13295
4 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9493
5 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9539
6 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3667
7 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3723
8 GRAPHIC g92412image002.jpg GRAPHIC 2726
  Complete submission text file 0001193125-06-054858.txt   1812153
Mailing Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060
Business Address 16825 NORTHCHASE DRIVE, SUITE 1300 HOUSTON TX 77060 (832) 601-8766
US Oncology Holdings, Inc. (Filer) CIK: 0001333191 (see all company filings)

IRS No.: 200873619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-126922 | Film No.: 06687841
SIC: 8060 Services-Hospitals